Polar Asset Management Partners’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-322,800
Closed -$3.17M 855
2023
Q4
$3.17M Sell
322,800
-510,200
-61% -$4.17M 0.05% 302
2023
Q3
$6.96M Buy
833,000
+266,300
+47% +$3.04M 0.15% 180
2023
Q2
$7.54M Sell
566,700
-95,000
-14% -$1.15M 0.14% 194
2023
Q1
$7.66M Buy
+661,700
New +$6.58M 0.12% 243
2022
Q2
Sell
-476,500
Closed -$4.34M 1396
2022
Q1
$4.34M Buy
+476,500
New +$5.49M 0.05% 477
2019
Q3
Sell
-475,000
Closed -$2.87M 442
2019
Q2
$2.87M Buy
475,000
+380,000
+400% +$2.66M 0.05% 234
2019
Q1
$687K Buy
+95,000
New +$687K 0.02% 258

Other funds holding PACB